{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T19:40:10Z","timestamp":1746733210242,"version":"3.40.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-025-01208-9","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T02:53:32Z","timestamp":1743821612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment and characterization of novel cancer cachexia-inducing cell line, Aku60GC, of scirrhous gastric cancer"],"prefix":"10.1007","volume":"38","author":[{"given":"Rei","family":"Noguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Iino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yomogi","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Seyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6405-7792","authenticated-orcid":false,"given":"Tadashi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"issue":"5","key":"1208_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489\u201395. https:\/\/doi.org\/10.1016\/S1470-2045(10)70218-7.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1208_CR2","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/jcsm.13116","volume":"14","author":"L Yuan","year":"2023","unstructured":"Yuan L, Springer J, Palus S, Busquets S, Jove Q, Alves de Lima Junior E, et al. The atypical beta-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model. J Cachexia Sarcopenia Muscle. 2023;14(1):653\u201360. https:\/\/doi.org\/10.1002\/jcsm.13116.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"1208_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0167-5273(02)00235-8","volume":"85","author":"KC Fearon","year":"2002","unstructured":"Fearon KC, Moses AG. Cancer cachexia. Int J Cardiol. 2002;85(1):73\u201381. https:\/\/doi.org\/10.1016\/s0167-5273(02)00235-8.","journal-title":"Int J Cardiol"},{"issue":"11","key":"1208_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argiles","year":"2014","unstructured":"Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754\u201362. https:\/\/doi.org\/10.1038\/nrc3829.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"1208_CR5","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941\u201353. https:\/\/doi.org\/10.1002\/ijc.31937.","journal-title":"Int J Cancer"},{"issue":"2","key":"1208_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1148\/radiol.2312030248","volume":"231","author":"MS Park","year":"2004","unstructured":"Park MS, Ha HK, Choi BS, Kim KW, Myung SJ, Kim AY, et al. Scirrhous gastric carcinoma: endoscopy versus upper gastrointestinal radiography. Radiology. 2004;231(2):421\u20136. https:\/\/doi.org\/10.1148\/radiol.2312030248.","journal-title":"Radiology"},{"issue":"1","key":"1208_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s10120-017-0716-7","volume":"21","author":"H Katai","year":"2018","unstructured":"Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001\u20132007). Gastric Cancer. 2018;21(1):144\u201354. https:\/\/doi.org\/10.1007\/s10120-017-0716-7.","journal-title":"Gastric Cancer"},{"issue":"7517","key":"1208_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202\u20139. https:\/\/doi.org\/10.1038\/nature13480.","journal-title":"Nature"},{"issue":"1","key":"1208_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-012-0163-4","volume":"16","author":"A Nashimoto","year":"2013","unstructured":"Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16(1):1\u201327. https:\/\/doi.org\/10.1007\/s10120-012-0163-4.","journal-title":"Gastric Cancer"},{"issue":"3","key":"1208_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF02306612","volume":"4","author":"H Furukawa","year":"1997","unstructured":"Furukawa H, Hiratsuka M, Iwanaga T, Imaoka S, Ishikawa O, Kabuto T, et al. Extended surgery\u2013left upper abdominal exenteration plus Appleby\u2019s method\u2013for type 4 gastric carcinoma. Ann Surg Oncol. 1997;4(3):209\u201314. https:\/\/doi.org\/10.1007\/BF02306612.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1208_CR11","doi-asserted-by":"publisher","first-page":"930","DOI":"10.2169\/internalmedicine.35.930","volume":"35","author":"S Suga","year":"1996","unstructured":"Suga S, Iwase H, Shimada M, Nishio Y, Ichihara T, Ichihara S, et al. Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin. Intern Med. 1996;35(12):930\u20136. https:\/\/doi.org\/10.2169\/internalmedicine.35.930.","journal-title":"Intern Med"},{"issue":"11","key":"1208_CR12","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1007\/s00595-022-02493-9","volume":"52","author":"T Namikawa","year":"2022","unstructured":"Namikawa T, Marui A, Yokota K, Fujieda Y, Munekage M, Uemura S, et al. Frequency and prognostic impact of cachexia during drug treatment for unresectable advanced gastric cancer patients. Surg Today. 2022;52(11):1560\u20137. https:\/\/doi.org\/10.1007\/s00595-022-02493-9.","journal-title":"Surg Today"},{"issue":"1","key":"1208_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00520-020-05479-w","volume":"29","author":"M Fukahori","year":"2021","unstructured":"Fukahori M, Shibata M, Hamauchi S, Kasamatsu E, Machii K. A retrospective cohort study to investigate the incidence of cancer-related weight loss during chemotherapy in gastric cancer patients. Support Care Cancer. 2021;29(1):341\u20138. https:\/\/doi.org\/10.1007\/s00520-020-05479-w.","journal-title":"Support Care Cancer"},{"issue":"25","key":"1208_CR14","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.18632\/oncotarget.26764","volume":"10","author":"K Yanagihara","year":"2019","unstructured":"Yanagihara K, Kubo T, Iino Y, Mihara K, Morimoto C, Seyama T, et al. Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line. Oncotarget. 2019;10(25):2435\u201350. https:\/\/doi.org\/10.18632\/oncotarget.26764.","journal-title":"Oncotarget"},{"issue":"7","key":"1208_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1349-7006.2004.tb02489.x","volume":"95","author":"K Yanagihara","year":"2004","unstructured":"Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y, Toge T, et al. Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci. 2004;95(7):575\u201382. https:\/\/doi.org\/10.1111\/j.1349-7006.2004.tb02489.x.","journal-title":"Cancer Sci"},{"issue":"5","key":"1208_CR16","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1007\/s13577-023-00928-0","volume":"36","author":"T Ono","year":"2023","unstructured":"Ono T, Noguchi R, Yoshimatsu Y, Sin Y, Tsuchiya R, Akiyama T, et al. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone. Hum Cell. 2023;36(5):1804\u201312. https:\/\/doi.org\/10.1007\/s13577-023-00928-0.","journal-title":"Hum Cell"},{"issue":"16","key":"1208_CR17","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352.","journal-title":"Bioinformatics"},{"issue":"9","key":"1208_CR18","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303. https:\/\/doi.org\/10.1101\/gr.107524.110.","journal-title":"Genome Res"},{"issue":"3","key":"1208_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31(3):213\u20139. https:\/\/doi.org\/10.1038\/nbt.2514.","journal-title":"Nat Biotechnol"},{"issue":"14","key":"1208_CR20","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders CT, Wong WS, Swamy S, Becq J, Murray LJ, Cheetham RK. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics. 2012;28(14):1811\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/bts271.","journal-title":"Bioinformatics"},{"issue":"16","key":"1208_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16): e164. https:\/\/doi.org\/10.1093\/nar\/gkq603.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1208_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.yexmp.2014.10.002","volume":"97","author":"HS Yang","year":"2014","unstructured":"Yang HS, Horten B. Gain of copy number and amplification of the RET gene in lung cancer. Exp Mol Pathol. 2014;97(3):465\u20139. https:\/\/doi.org\/10.1016\/j.yexmp.2014.10.002.","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"1208_CR23","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.1152\/ajpendo.00116.2013","volume":"306","author":"K Terawaki","year":"2014","unstructured":"Terawaki K, Sawada Y, Kashiwase Y, Hashimoto H, Yoshimura M, Suzuki M, et al. New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line. Am J Physiol Endocrinol Metab. 2014;306(4):E373\u201387. https:\/\/doi.org\/10.1152\/ajpendo.00116.2013.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"1208_CR24","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/01635581.2013.776089","volume":"65","author":"K Yanagihara","year":"2013","unstructured":"Yanagihara K, Takigahira M, Mihara K, Kubo T, Morimoto C, Morita Y, et al. Inhibitory effects of isoflavones on tumor growth and cachexia in newly established cachectic mouse models carrying human stomach cancers. Nutr Cancer. 2013;65(4):578\u201389. https:\/\/doi.org\/10.1080\/01635581.2013.776089.","journal-title":"Nutr Cancer"},{"issue":"3","key":"1208_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173113","volume":"12","author":"K Terawaki","year":"2017","unstructured":"Terawaki K, Kashiwase Y, Sawada Y, Hashimoto H, Yoshimura M, Ohbuchi K, et al. Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model. PLoS ONE. 2017;12(3): e0173113. https:\/\/doi.org\/10.1371\/journal.pone.0173113.","journal-title":"PLoS ONE"},{"issue":"78","key":"1208_CR26","doi-asserted-by":"publisher","first-page":"34748","DOI":"10.18632\/oncotarget.26190","volume":"9","author":"K Terawaki","year":"2018","unstructured":"Terawaki K, Kashiwase Y, Uzu M, Nonaka M, Sawada Y, Miyano K, et al. Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85As2 cells in rats. Oncotarget. 2018;9(78):34748\u201364. https:\/\/doi.org\/10.18632\/oncotarget.26190.","journal-title":"Oncotarget"},{"issue":"2","key":"1208_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KC Fearon","year":"2012","unstructured":"Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012;16(2):153\u201366. https:\/\/doi.org\/10.1016\/j.cmet.2012.06.011.","journal-title":"Cell Metab"},{"issue":"21","key":"1208_CR28","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","volume":"14","author":"DJ Waugh","year":"2008","unstructured":"Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14(21):6735\u201341. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4843.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1208_CR29","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/cncr.11178","volume":"97","author":"J Pfitzenmaier","year":"2003","unstructured":"Pfitzenmaier J, Vessella R, Higano CS, Noteboom JL, Wallace D Jr, Corey E. Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer. 2003;97(5):1211\u20136. https:\/\/doi.org\/10.1002\/cncr.11178.","journal-title":"Cancer"},{"issue":"18","key":"1208_CR30","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.clinbiochem.2007.07.013","volume":"40","author":"M Krzystek-Korpacka","year":"2007","unstructured":"Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Kustrzeba-Wojcicka I, et al. Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-alpha, VEGF-A, VEGF-C and midkine in gastroesophageal cancer patients. Clin Biochem. 2007;40(18):1353\u201360. https:\/\/doi.org\/10.1016\/j.clinbiochem.2007.07.013.","journal-title":"Clin Biochem"},{"key":"1208_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.biopha.2014.12.040","volume":"70","author":"F Tas","year":"2015","unstructured":"Tas F, Tilgen Yasasever C, Karabulut S, Tastekin D, Duranyildiz D. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer. Biomed Pharmacother. 2015;70:19\u201323. https:\/\/doi.org\/10.1016\/j.biopha.2014.12.040.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1208_CR32","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.4049\/jimmunol.0801695","volume":"182","author":"KE Kim","year":"2009","unstructured":"Kim KE, Song H, Hahm C, Yoon SY, Park S, Lee HR, et al. Expression of ADAM33 is a novel regulatory mechanism in IL-18-secreted process in gastric cancer. J Immunol. 2009;182(6):3548\u201355. https:\/\/doi.org\/10.4049\/jimmunol.0801695.","journal-title":"J Immunol"},{"issue":"2","key":"1208_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ijc.21334","volume":"118","author":"T Majima","year":"2006","unstructured":"Majima T, Ichikura T, Chochi K, Kawabata T, Tsujimoto H, Sugasawa H, et al. Exploitation of interleukin-18 by gastric cancers for their growth and evasion of host immunity. Int J Cancer. 2006;118(2):388\u201395. https:\/\/doi.org\/10.1002\/ijc.21334.","journal-title":"Int J Cancer"},{"issue":"12","key":"1208_CR34","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/carcin\/bgp158","volume":"30","author":"JS Kang","year":"2009","unstructured":"Kang JS, Bae SY, Kim HR, Kim YS, Kim DJ, Cho BJ, et al. Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44. Carcinogenesis. 2009;30(12):1987\u201396. https:\/\/doi.org\/10.1093\/carcin\/bgp158.","journal-title":"Carcinogenesis"},{"issue":"3","key":"1208_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/jcsm.13430","volume":"15","author":"B Gagnon","year":"2024","unstructured":"Gagnon B, Murphy J, Simonyan D, Penafuerte CA, Sirois J, Chasen M, et al. Cancer anorexia-cachexia syndrome is characterized by more than one inflammatory pathway. J Cachexia Sarcopenia Muscle. 2024;15(3):1041\u201353. https:\/\/doi.org\/10.1002\/jcsm.13430.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10","key":"1208_CR36","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1007\/s00125-007-0732-y","volume":"50","author":"GP Fadini","year":"2007","unstructured":"Fadini GP, Pucci L, Vanacore R, Baesso I, Penno G, Balbarini A, et al. Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia. 2007;50(10):2156\u201363. https:\/\/doi.org\/10.1007\/s00125-007-0732-y.","journal-title":"Diabetologia"},{"issue":"1","key":"1208_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/gcc.22683","volume":"58","author":"J Koh","year":"2019","unstructured":"Koh J, Nam SK, Roh H, Kim J, Lee BC, Kim JW, et al. Somatic mutational profiles of stage II and III gastric cancer according to tumor microenvironment immune type. Genes Chromosomes Cancer. 2019;58(1):12\u201322. https:\/\/doi.org\/10.1002\/gcc.22683.","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"1208_CR38","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/jcsm.13023","volume":"13","author":"H Lin","year":"2022","unstructured":"Lin H, Ma X, Sun Y, Peng H, Wang Y, Thomas SS, et al. Decoding the transcriptome of denervated muscle at single-nucleus resolution. J Cachexia Sarcopenia Muscle. 2022;13(4):2102\u201317. https:\/\/doi.org\/10.1002\/jcsm.13023.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"14","key":"1208_CR39","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1101\/gad.1318305","volume":"19","author":"X Wang","year":"2005","unstructured":"Wang X, Blagden C, Fan J, Nowak SJ, Taniuchi I, Littman DR, et al. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes Dev. 2005;19(14):1715\u201322. https:\/\/doi.org\/10.1101\/gad.1318305.","journal-title":"Genes Dev"},{"issue":"3","key":"1208_CR40","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3892\/ijo.2015.3306","volume":"48","author":"GM Nitulescu","year":"2016","unstructured":"Nitulescu GM, Margina D, Juzenas P, Peng Q, Olaru OT, Saloustros E, et al. Akt inhibitors in cancer treatment: the long journey from drug discovery to clinical use (Review). Int J Oncol. 2016;48(3):869\u201385. https:\/\/doi.org\/10.3892\/ijo.2015.3306.","journal-title":"Int J Oncol"},{"issue":"6","key":"1208_CR41","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/07853890.2014.912836","volume":"46","author":"M Martini","year":"2014","unstructured":"Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. PI3K\/AKT signaling pathway and cancer: an updated review. Ann Med. 2014;46(6):372\u201383. https:\/\/doi.org\/10.3109\/07853890.2014.912836.","journal-title":"Ann Med"},{"issue":"22","key":"1208_CR42","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1038\/sj.onc.1205438","volume":"21","author":"SS Bacus","year":"2002","unstructured":"Bacus SS, Altomare DA, Lyass L, Chin DM, Farrell MP, Gurova K, et al. AKT2 is frequently upregulated in HER-2\/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival. Oncogene. 2002;21(22):3532\u201340. https:\/\/doi.org\/10.1038\/sj.onc.1205438.","journal-title":"Oncogene"},{"issue":"51","key":"1208_CR43","doi-asserted-by":"publisher","first-page":"20315","DOI":"10.1073\/pnas.0810715105","volume":"105","author":"PG Rychahou","year":"2008","unstructured":"Rychahou PG, Kang J, Gulhati P, Doan HQ, Chen LA, Xiao SY, et al. Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proc Natl Acad Sci U S A. 2008;105(51):20315\u201320. https:\/\/doi.org\/10.1073\/pnas.0810715105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1208_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092107","author":"SS Ahmad","year":"2022","unstructured":"Ahmad SS, Ahmad K, Shaikh S, You HJ, Lee EY, Ali S, et al. Molecular mechanisms and current treatment options for cancer cachexia. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14092107.","journal-title":"Cancers (Basel)."},{"issue":"2","key":"1208_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/mus.20442","volume":"33","author":"SC Kandarian","year":"2006","unstructured":"Kandarian SC, Jackman RW. Intracellular signaling during skeletal muscle atrophy. Muscle Nerve. 2006;33(2):155\u201365. https:\/\/doi.org\/10.1002\/mus.20442.","journal-title":"Muscle Nerve"},{"issue":"6","key":"1208_CR46","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3892\/ijo.2013.1893","volume":"42","author":"ND Manne","year":"2013","unstructured":"Manne ND, Lima M, Enos RT, Wehner P, Carson JA, Blough E. Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin\/+ mouse. Int J Oncol. 2013;42(6):2134\u201340. https:\/\/doi.org\/10.3892\/ijo.2013.1893.","journal-title":"Int J Oncol"},{"key":"1208_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123527","author":"PP Freire","year":"2021","unstructured":"Freire PP, Cury SS, Lopes LO, Fernandez GJ, Liu J, de Moraes LN, et al. Decreased miR-497-5p suppresses IL-6 induced atrophy in muscle cells. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10123527.","journal-title":"Cells"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01208-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-025-01208-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01208-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T19:02:40Z","timestamp":1746730960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-025-01208-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1007\/s13577-025-01208-9","relation":{},"ISSN":["1749-0774"],"issn-type":[{"type":"electronic","value":"1749-0774"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The use of clinical materials for this study was approved by the Ethical Committees in Animal Experimentation of the National Cancer Center and Yasuda Women\u2019s University in accordance with the Institutional and Japanese Government Guidelines for Animal experiments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"82"}}